Impact Of Risk Evaluation And Mitigation Strategies On Generic Approvals Of US Pharmaceutical Products.
Sign Up to like & getrecommendations! Published in 2025 at "Health affairs"
DOI: 10.1377/hlthaff.2024.01476
Abstract: Risk evaluation and mitigation strategy (REMS) programs help ensure that the benefits of certain high-risk medications outweigh their risks. With the routine use of REMS programs, however, concerns have emerged that they may delay the… read more here.
Keywords: risk evaluation; evaluation mitigation; risk; generic approvals ... See more keywords